Skip Navigation
Skip Website Tools

Dengue Fever

Skip Content Marketing
  • Share this:
  • submit to facebook
  • Tweet it
  • submit to reddit
  • submit to StumbleUpon
  • submit to Google +

NIAID Role in Dengue Fever Research

Early diagnosis and treatment of dengue is critical as epidemics of the disease become larger and more frequent. An estimated 50 to 100 million people contract dengue each year in over 100 countries. Left untreated, patients may experience hemorrhage and shock, leading to death.

Recognizing the threat to public health posed by dengue, NIAID is funding nearly 60 dengue research projects, including studies on dengue hemorrhagic fever and dengue shock syndrome, the most severe forms of the disease. NIAID research priorities include effective community-based prevention programs, improved laboratory-based international surveillance, rapid diagnostic tests and therapies, and development of and clinical trials for dengue vaccines. Learn more about NIAID dengue fever research.

Last Updated December 05, 2013